Zhun F. Bi
Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Essential oil from Chrysanthemi Flos alleviates the nitroglycerin-induced migraine in mice by regulating the vasoactive substances and the PI3K/AKT signal pathway.
Journal: Journal of ethnopharmacology
Published: August 30, 2025
Jiegeng decoction ameliorated acute pharyngitis through suppressing NF-κB and MAPK signaling pathways.
Journal: Journal of ethnopharmacology
Published: December 01, 2023
Progress in research of long-term protective efficacy of human papillomavirus vaccine
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: May 23, 2023
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
Journal: BMC pulmonary medicine
Published: September 07, 2022
Myricetin reverses epithelial-endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1.
Journal: Phytotherapy research : PTR
Published: November 09, 2021
Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway.
Journal: Phytotherapy research : PTR
Published: April 10, 2021
Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice.
Journal: Frontiers in pharmacology
Published: April 08, 2021
Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
Journal: Biochemical pharmacology
Published: January 24, 2020
Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice.
Journal: Journal of cellular and molecular medicine
Published: January 09, 2020
Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1.
Journal: Frontiers in oncology
Published: September 30, 2019
Corrigendum to 'Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-b1 pathway' [Eur. J. Med. Chem. 157 (2018) 229-247].
Journal: European journal of medicinal chemistry
Published: December 12, 2018
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice.
Journal: Frontiers in pharmacology
Published: October 10, 2018
Last Updated: 09/26/2026